Inducible Clindamycin Resistant Staphylococcus aureus among Patients Attending Tertiary Care Centre: A Descriptive

Shanti Pradhan1, Sanjib Mani Regmi1, Nabina Shrestha1

  • 1Gandaki Medical College and Teaching Hospital and Research Centre, Pokhara, Nepal.

Abstract

Insights

High rates of inducible clindamycin resistance in Staphylococcus aureus, particularly methicillin-resistant strains, were found. This highlights the urgent need for routine D-testing to guide antibiotic choices and prevent treatment failures.

Area of Science:

  • Clinical microbiology
  • Infectious diseases
  • Antimicrobial resistance

Background:

  • Staphylococcus aureus is a significant pathogen, with rising resistance to antibiotics.
  • Macrolide-lincosamide-streptogramin B (MLSB) antibiotics are increasingly used but face emerging resistance.
  • Inducible clindamycin resistance in S. aureus is a growing concern.

Purpose of the Study:

  • To determine the prevalence of inducible clindamycin-resistant Staphylococcus aureus in a tertiary care center.
  • To assess the co-resistance patterns in methicillin-resistant Staphylococcus aureus (MRSA).

Main Methods:

  • A descriptive cross-sectional study of clinical isolates from September 2020 to May 2021.
  • Antibiotic susceptibility testing using disc diffusion and D-test for inducible resistance.
  • Cefoxitin disc used for methicillin resistance detection.

Main Results:

  • Out of 141 S. aureus isolates, 29.1% exhibited inducible clindamycin resistance.
  • Constitutive clindamycin resistance was observed in 21.3% of isolates.
  • Inducible and constitutive resistance were higher in MRSA isolates (47.5% and 32.2%, respectively).

Conclusions:

  • A high frequency of inducible clindamycin resistance in MRSA necessitates caution with MLSB antibiotic use.
  • Routine D-testing is crucial for identifying inducible resistance and preventing treatment failure.
  • This finding underscores the importance of antimicrobial stewardship programs.

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.7K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.1K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
60